Quantification of the virus-host interaction in human T lymphotropic virus I infection
<p>Abstract</p> <p>Background</p> <p>HTLV-I causes the disabling inflammatory disease HAM/TSP: there is no vaccine, no satisfactory treatment and no means of assessing the risk of disease or prognosis in infected people. Like many immunopathological diseases with a vira...
Main Authors: | Taylor Graham P, Tanaka Yuetsu, Heaps Adrian, Mosley Angelina J, Asquith Becca, McLean Angela R, Bangham Charles RM |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2005-12-01
|
Series: | Retrovirology |
Online Access: | http://www.retrovirology.com/content/2/1/75 |
Similar Items
-
Human T-lymphotropic virus-1 visualized at the virological synapse by electron tomography.
by: Endre Majorovits, et al.
Published: (2008-05-01) -
Strongyloidiasis and infective dermatitis alter human T lymphotropic virus-1 clonality in vivo.
by: Nicolas A Gillet, et al.
Published: (2013-01-01) -
Zidovudine plus lamivudine in Human T-Lymphotropic Virus type-I-associated myelopathy: a randomised trial
by: Rudge Peter, et al.
Published: (2006-09-01) -
Human T Lymphotropic Virus and Pulmonary Diseases
by: Apio R. N. Dias, et al.
Published: (2018-08-01) -
Human T-lymphotropic virus type 1(HTLV-1) integration, HTLV-1-associated infective dermatitis (IDH) and the risk of Adult T cell leukaemia/lymphoma (ATLL)
by: Ogg Graham, et al.
Published: (2011-06-01)